Skip to main content

Show 49 results Show all

The Future of DMPA-SC: Expanding access and options in 2019

The working meeting on “The Future of DMPA-SC: Expanding access and options in 2019” was held in November 2018 as a pre-meeting before the International Conference on Family Planning (ICFP) in Kigali, Rwanda was intended to bring together colleagues and partners working to introduce and scale-up subcutaneous DMPA (DMPA-SC or SC) in 14 countries to exchange challenges, successes, and lessons learned—and to plan together how they can continue to expand women’s access and options with DMPA-SC.

Institutional Author(s): PATH
Publication date: January, 2019

Report The Future of DMPA-SC: Expanding access and options in 2019

Community-Based Access to Injectable Contraceptives (CBA2I): Select Resources

Community-based access to injectable contraceptives (CBA2I) is an important strategy for addressing the reproductive health needs of women and couples wishing to limit or space pregnancies. The resources in this list aim to help stakeholders effectively implement CBA2I programs.

Institutional Author(s): FHI 360
Publication date: June, 2018

Community-Based Access to Injectable Contraceptives (CBA2I): Select Resources

Monitoring the introduction of DMPA-SC

From 2014 to 2016, PATH coordinated pilot introduction of the injectable contraceptive subcutaneous DMPA (DMPA-SC, brand name Sayana® Press) in Burkina Faso, Niger, Senegal, and Uganda. These materials feature guidance for monitoring DMPA-SC introductions, monitoring results, and lessons learned, which can help inform contraceptive introduction programming for DMPA-SC and other methods.

Institutional Author(s): PATH
Publication date: March, 2018

Operational assessments of Sayana® Press provision in Senegal and Uganda

This study aimed to evaluate DMPA-SC (Sayana Press) management and administration in low-resource settings, focusing on how the delivery logistics, administration time, storage and waste-management requirements compare to the traditional intramuscular DMPA injectable (DMPA-IM).

Cover J, Blanton E, Ndiaye D, Walugembe F, Lamontagne DS. Operational assessments of Sayana® Press provision in Senegal and Uganda. Contraception. 2014 May;89(5):374-8. https://doi.org/10.1016/j.contraception.2014.01.005. Epub 2014 Jan 18. PMID: 24565737.

Institutional Author(s): PATH
Individual Author(s): Jane Cover, Elizabeth Blanton, Dieynaba Ndiaye, Fiona Walugembe, D Scott Lamontagne
Publication date: January, 2014

Journal Article Operational assessments of Sayana® Press provision in Senegal and Uganda

Acceptability of depo-subQ in Uniject

FHI 360’s PROGRESS project worked with ministries of health and local partners in Senegal and Uganda to conduct an acceptability study of the subcutaneous delivery of injectable contraceptives with the Uniject™ device (DMPA-SC, Sayana® Press). The study assessed acceptability among family planning clients and providers, including community health workers, and offered recommendations for the introduction of this method.

Institutional Author(s): FHI 360
Publication date: June, 2013

Operational Assessment: Administration and Management of Sayana® Press in Clinics and Communities in Uganda

This operational assessment in Uganda examines the extent to which DMPA-SC (brand name Sayana® Press) facilitates the logistics of managing and administering injectable contraception and assesses whether providers in Uganda find benefits in this new presentation.

Institutional Author(s): PATH
Publication date: May, 2013

Brief Operational Assessment: Administration and Management of Sayana® Press in Clinics and Communities in Uganda

Key Indicators for Community-based Access to Injectable Contraception Pilot Studies

An indicator is a measure of program performance that is tracked over time. This document presents potential process and outcome indicators organized according to phase of the community-based access to injectables (CBA2I) pilot along with the related evaluation questions, data sources and measurement tools. The list can be adapted to local context and program goals to assess a pilot’s progress toward intended outputs and achievement of goals.

Institutional Author(s): FHI 360
Publication date: 2011

Logistics and Waste Management Benefits of depo-subQ in Uniject

This four-page brief describes results from three analyses conducted by PATH and John Snow Inc. (JSI) comparing the intramuscular version of depot medroxyprogesterone acetate (DMPA) injectable contraceptive compared with the new DMPA-SC formulation packaged in the Uniject injection system. The analyses focused on waste management implications and identified key quantitative and qualitative differences between the two products.

Institutional Author(s): PATH, JSI, Inc.
Publication date: February, 2011